Skip to main content

Table 3 Testing of models using independent data

From: A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches

Model

Predicted mean (SE) [95% CI]

R2

RMSE

% of 95% CI containing the observed mean‡

Beta (a)*

0.747 (0.0069)

0.75

0.132

77%

[0.733, 0.760]

Beta (b)†

0.622 (0.0057)

0.61

0.159

59%

[0.608, 0.631]

CLAD (a)*

0.671 (0.0091)

0.56

0.027

28%

[0.652, 0.689]

CLAD (b)†

0.652 (0.0054)

0.47

0.154

19%

[0.639, 0.660]

Linear Mixed (a)*

0.738 (0.0051)

0.63

0.019

45%

[0.728, 0.747]

Linear Mixed (b)†

0.642 (0.0059)

0.58

0.095

23%

[0.630, 0.653]

Quadratic (a)*

0.768 (0.0056)

0.63

0.018

37%

[0.757, 0.778]

Quadratic (b)†

0.636 (0.0039)

0.55

0.093

14%

[0.628, 0.643]

TOBIT (a)*

0.739 (0.014)

0.56

0.021

65%

[0.702, 0.757]

TOBIT (b)†

0.644 (0.0084)

0.59

0.112

24%

[0.627, 0.660]

Quantile (a)*

0.772 (0.0060)

0.62

0.190

21%

[0.754, 0.778]

Quantile (b)†

0.661 (0.0084)

0.58

0.148

8%

[0.644, 0.677]

  1. *Model developed from TOPICAL trial and tested using SOCCAR Data.
  2. †Model developed from SOCCAR trial and tested using TOPICAL Data.
  3. ‡based on 10,000 monte-carlo simulations.